SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002792
Filing Date
2017-04-21
Accepted
2017-04-21 08:01:22
Documents
11
Period of Report
2017-06-13
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231889zdef14a.htm DEF 14A 678707
2 G701037.JPG g701037.jpg GRAPHIC 19481
3 G998358.JPG g998358.jpg GRAPHIC 15497
4 G971758.JPG g971758.jpg GRAPHIC 18907
5 G1046976.JPG g1046976.jpg GRAPHIC 54954
6 G282961.JPG g282961.jpg GRAPHIC 63686
7 G705179.JPG g705179.jpg GRAPHIC 21193
8 G411319.JPG g411319.jpg GRAPHIC 14710
9 G599367.JPG g599367.jpg GRAPHIC 42070
10 G23842BCI001.GIF g23842bci001.gif GRAPHIC 198448
11 G23842BCI002.GIF g23842bci002.gif GRAPHIC 135892
  Complete submission text file 0001047469-17-002792.txt   1486273
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 17774241
SIC: 2834 Pharmaceutical Preparations